Atezolizumab Video indir

Les Effets Indésirables Les Plus Fréquents De Latezolizumab
2:22
651
NetCancer
Les Effets Indésirables Les Plus Fréquents De Latezolizumab
4 yıl önce
Küçük Hücreli Akciğer Kanseri İlk Sıra Tedavide İmmünoterapi Impower-133 Çalışmasıyla Fda Onayı Aldı
3:09
16.054
Prof. Dr. Mustafa Özdoğan
Küçük Hücreli Akciğer Kanseri İlk Sıra Tedavide İmmünoterapi Impower-133...
5 yıl önce
Choosing Between Atezolizumab And Pembrolizumab In Lung Cancer
3:01
6.822
Targeted Oncology
Choosing Between Atezolizumab And Pembrolizumab In Lung Cancer
8 yıl önce
Dr. Melissa Johnson On Atezolizumab In Patients With Nsclc
1:50
2.288
OncLive
Dr. Melissa Johnson On Atezolizumab In Patients With Nsclc
10 yıl önce
Comparing Atezolizumab Bevacizumab With Stride In Advanced Hcc
1:32
475
VJOncology
Comparing Atezolizumab Bevacizumab With Stride In Advanced Hcc
11 ay önce
Real-World Survival Outcomes With Atezolizumab Versus Durvalumab In Extensive-Stage Sclc
1:39
55
VJOncology
Real-World Survival Outcomes With Atezolizumab Versus Durvalumab In...
2 ay önce
Dr. Horn Discusses Next Steps With Atezolizumab In Sclc
1:12
553
OncLive
Dr. Horn Discusses Next Steps With Atezolizumab In Sclc
7 yıl önce
Real-World Study Of Atezolizumab Vs. Pembrolizumab For Advancedmetastatic Uc
2:12
877
VJOncology
Real-World Study Of Atezolizumab Vs. Pembrolizumab For Advancedmetastatic Uc
4 yıl önce
Imbrave050 Adjuvant Atezolizumab With Bevacizumab In High-Risk Hcc
3:42
967
VJOncology
Imbrave050 Adjuvant Atezolizumab With Bevacizumab In High-Risk Hcc
3 yıl önce
Impower 010 Adjuvant Atezolizumab In Nsclc - Onctalk Lung 2023
1:58
264
Global Resource for Advancing Cancer Education
Impower 010 Adjuvant Atezolizumab In Nsclc - Onctalk Lung 2023
2 yıl önce
Dr. Horn On The Fda Approval Of Atezolizumab Plus Bevacizumab And Chemotherapy In Nsclc
1:08
894
OncLive
Dr. Horn On The Fda Approval Of Atezolizumab Plus Bevacizumab And Chemotherapy...
7 yıl önce
Dr. Pishvaian Discusses Atezolizumab Plus Bevacizumab In Hcc
1:03
770
OncLive
Dr. Pishvaian Discusses Atezolizumab Plus Bevacizumab In Hcc
7 yıl önce
Cobimetinib And Atezolizumab In Colorectal Cancer
1:17
465
Cancer Therapy Advisor
Cobimetinib And Atezolizumab In Colorectal Cancer
10 yıl önce
Impower110 Atezolizumab Vs Chemo In Pd-L1Selected Nsclc
4:18
1.343
VJOncology
Impower110 Atezolizumab Vs Chemo In Pd-L1Selected Nsclc
6 yıl önce
Dr. Overman On The Combination Of Atezolizumab And Bevacizumab In Hcc
1:30
985
OncLive
Dr. Overman On The Combination Of Atezolizumab And Bevacizumab In Hcc
7 yıl önce
Atezolizumab Monotherapy Vs Docetaxel In 2Nd And 3Rd Line Nsclc
6:06
242
ecancer
Atezolizumab Monotherapy Vs Docetaxel In 2Nd And 3Rd Line Nsclc
10 yıl önce
Key Outcomes Of The Phase 1B Of Atezolizumab And Bevacizumab For Advanced Hcc
2:40
465
VJOncology
Key Outcomes Of The Phase 1B Of Atezolizumab And Bevacizumab For Advanced Hcc
7 yıl önce
Adjuvant Atezolizumab In Nsclc
1:41
464
VJOncology
Adjuvant Atezolizumab In Nsclc
4 yıl önce
Combination Atezolizumab Plus Bevacizumab Improved Quality Of Life In Hcc
0:37
958
Targeted Oncology
Combination Atezolizumab Plus Bevacizumab Improved Quality Of Life In Hcc
6 yıl önce
What Are Possible Side Effects Associated With Bevacizumab And Atezolizumab For Liver Cancer?
6:45
744
PRECISCA
What Are Possible Side Effects Associated With Bevacizumab And Atezolizumab For...
1 yıl önce
Folfox Alone Or Combined With Atezolizumab As Adjuvant Therapy In Stage Iii Colon Cancer Atomic
1:47
318
Oncology.TV
Folfox Alone Or Combined With Atezolizumab As Adjuvant Therapy In Stage Iii...
9 yıl önce
Dr. Rini On The Tolerability Of Atezolizumab Plus Bevacizumab In Rcc
1:27
158
OncLive
Dr. Rini On The Tolerability Of Atezolizumab Plus Bevacizumab In Rcc
8 yıl önce
Atezolizumab Bevacizumab In Treatment-Naïve Mrcc
3:44
1.145
OncLive
Atezolizumab Bevacizumab In Treatment-Naïve Mrcc
8 yıl önce
Impower133 Atezolizumab, Carboplatin Plus Etoposide For Sclc
1:50
1.088
VJOncology
Impower133 Atezolizumab, Carboplatin Plus Etoposide For Sclc
6 yıl önce
Atezolizumab In Urothelial Bladder Cancer
1:47
242
Cancer Therapy Advisor
Atezolizumab In Urothelial Bladder Cancer
10 yıl önce
Stellar-303 Xl092 With Atezolizumab Or Regorafenib In Patients With Mcrc
2:32
469
VJOncology
Stellar-303 Xl092 With Atezolizumab Or Regorafenib In Patients With Mcrc
3 yıl önce
Impower010 Atezolizumab Versus Best Supportive Care After Adjuvant Chemotherapy In Resected Nsclc
8:20
155
ecancer
Impower010 Atezolizumab Versus Best Supportive Care After Adjuvant Chemotherapy...
5 yıl önce
Atezolizumab New Genentech Drug Targets Cancers First Line Of Defense
10:08
1.427
The Doctor Weighs In
Atezolizumab New Genentech Drug Targets Cancers First Line Of Defense
10 yıl önce
Investigating At-Home Subcutaneous Atezolizumab For Nsclc An Ongoing Study
4:30
38
ReachMD
Investigating At-Home Subcutaneous Atezolizumab For Nsclc An Ongoing Study
1 yıl önce
Significant Survival Gains With Atezolizumab For Nsclc
4:01
625
ecancer
Significant Survival Gains With Atezolizumab For Nsclc
9 yıl önce
Atezolizumab In Formulazione Sottocutanea Lupdate Dello Studio Imscin001 E Le Sue Implicazioni
3:07
216
OncoInfoTV
Atezolizumab In Formulazione Sottocutanea Lupdate Dello Studio Imscin001 E Le...
9 ay önce
Atezolizumab For Tnbc
0:47
422
VJOncology
Atezolizumab For Tnbc
7 yıl önce
Triplet-Hcc Ipilimumab, Atezolizumab, And Bevacizumab In 1L Uhcc
1:50
45
VJOncology
Triplet-Hcc Ipilimumab, Atezolizumab, And Bevacizumab In 1L Uhcc
8 ay önce
Neoadjuvant Atezolizumab A For Resectable Non-Small Cell Lung Cancer
2:21
76
OncologyTube
Neoadjuvant Atezolizumab A For Resectable Non-Small Cell Lung Cancer
5 yıl önce
Fda Approves Atezolizumab Tecentriq Hybreza For Subcutaneous Pd-L1 Cancer Immunotherapy In Nsclc
1:52
8.527
OncologyTube
Fda Approves Atezolizumab Tecentriq Hybreza For Subcutaneous Pd-L1 Cancer...
1 yıl önce
Selecting Atezolizumab Plus Bevacizumab Versus Ipilimumab Plus Nivolumab In Rcc
0:50
198
Targeted Oncology
Selecting Atezolizumab Plus Bevacizumab Versus Ipilimumab Plus Nivolumab In Rcc
7 yıl önce
Stellar-303 Xl092 With Atezolizumab Compared To Regorafenib In Patients With Mcrc
2:14
601
VJOncology
Stellar-303 Xl092 With Atezolizumab Compared To Regorafenib In Patients With...
3 yıl önce
Imvigor130 Data Atezolizumab Alone Or With Chemo Upfront For Bladder Cancer
4:20
365
VJOncology
Imvigor130 Data Atezolizumab Alone Or With Chemo Upfront For Bladder Cancer
6 yıl önce
© 2026 VideoindirXa.Net by NEMO